Lauren M Aleksunes Selected Research

Subfamily B ATP Binding Cassette Transporter

9/2013	Assessment of drug transporter function using fluorescent cell imaging.
3/2010	Xenobiotic, bile acid, and cholesterol transporters: function and regulation.
9/2008	Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment.
9/2008	Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lauren M Aleksunes Research Topics

Disease

26	Breast Neoplasms (Breast Cancer) 10/2022 - 02/2006
10	Neoplasms (Cancer) 01/2020 - 06/2007
7	Acute Kidney Injury (Acute Renal Failure) 07/2022 - 09/2008
6	Inflammation (Inflammations) 01/2016 - 12/2008
5	Cholestasis 11/2016 - 01/2006
4	Intrahepatic Cholestasis 07/2009 - 04/2009
3	Choriocarcinoma 05/2017 - 04/2016
3	Necrosis 05/2014 - 09/2008
2	Liver Diseases (Liver Disease) 01/2022 - 04/2012
2	Hypoxia (Hypoxemia) 01/2021 - 01/2017
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2018 - 04/2016
2	Edema (Dropsy) 01/2016 - 01/2002
2	Liver Neoplasms (Liver Cancer) 01/2015 - 01/2010
2	Carcinogenesis 01/2013 - 03/2008
2	Obesity 06/2012 - 01/2008
2	Hyperglycemia 06/2012 - 04/2010
2	Drug-Related Side Effects and Adverse Reactions 04/2012 - 01/2002
2	Type 2 Diabetes Mellitus (MODY) 01/2008 - 01/2002
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 10/2007 - 03/2006
2	Disease Progression 06/2007 - 03/2006
1	Fetal Diseases (Embryopathy) 10/2022
1	Nausea 06/2021
1	Vomiting 06/2021
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Infertility (Sterility) 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Feminization 01/2018
1	Adenocarcinoma 11/2017

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 10/2022 - 02/2006
14	Pharmaceutical PreparationsIBA 06/2021 - 01/2002
11	Multidrug Resistance-Associated ProteinsIBA 10/2022 - 02/2006
11	Messenger RNA (mRNA)IBA 01/2021 - 05/2006
10	Cisplatin (Platino)FDA LinkGeneric 07/2022 - 09/2008
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2022 - 10/2007
6	Adenosine Triphosphate (ATP)IBA 01/2021 - 03/2010
6	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2015 - 02/2006
5	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 05/2009
4	XenobioticsIBA 05/2017 - 09/2008
4	EnzymesIBA 09/2016 - 03/2006
4	Subfamily B ATP Binding Cassette TransporterIBA 09/2013 - 09/2008
4	Peptides (Polypeptides)IBA 09/2008 - 02/2006
3	CalbindinsIBA 07/2022 - 01/2018
3	LipopolysaccharidesIBA 01/2021 - 12/2012
3	Member 2 Subfamily G ATP Binding Cassette TransporterIBA 01/2018 - 04/2016
3	Insulin (Novolin)FDA Link 01/2015 - 01/2002
3	Streptozocin (Streptozotocin)FDA Link 06/2012 - 01/2008
3	AnionsIBA 09/2008 - 01/2008
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2022 - 03/2010
2	CreatinineIBA 07/2022 - 01/2018
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2017
2	Histones (Histone)IBA 01/2020 - 06/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2020 - 06/2019
2	Histone Deacetylase InhibitorsIBA 01/2020 - 06/2019
2	Trefoil Factor-3IBA 01/2020 - 01/2018
2	Glyburide (Glibenclamide)FDA LinkGeneric 01/2018 - 04/2016
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2017 - 01/2010
2	Rosiglitazone (Avandia)FDA Link 05/2017 - 01/2002
2	LipidsIBA 11/2016 - 02/2013
2	BilirubinIBA 03/2016 - 05/2014
2	Glucose (Dextrose)FDA LinkGeneric 02/2013 - 04/2010
2	AntioxidantsIBA 04/2012 - 06/2007
2	Phenobarbital (Luminal)FDA Link 01/2010 - 05/2009
2	Lithocholic AcidIBA 07/2009 - 05/2009
2	CationsIBA 09/2008 - 01/2008
2	Taurocholic Acid (Sodium Taurocholate)IBA 01/2008 - 02/2006
2	Oxidoreductases (Dehydrogenase)IBA 03/2006 - 01/2006
2	NAD (NADH)IBA 03/2006 - 01/2006
2	quinone (benzoquinone)IBA 03/2006 - 01/2006
1	Urea (Carbamide)FDA LinkGeneric 07/2022
1	NitrogenIBA 07/2022
1	Ondansetron (Zofran)FDA LinkGeneric 06/2021
1	Serotonin 5-HT3 Receptor AntagonistsIBA 06/2021
1	CadmiumIBA 01/2021
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021
1	MelatoninIBA 01/2021
1	Heavy MetalsIBA 01/2021
1	Vancomycin FDA LinkGeneric 01/2021
1	Retinoid X Receptor alphaIBA 01/2021
1	AcidsIBA 01/2021
1	CytokinesIBA 01/2021
1	ZeranolIBA 01/2021
1	Diclofenac (SR 38)FDA LinkGeneric 10/2019
1	perfluorooctanoic acidIBA 01/2019
1	STAT5 Transcription FactorIBA 01/2018
1	Lipocalin-2IBA 01/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	Growth Hormone (Somatotropin)IBA 01/2018
1	beta 2-Microglobulin (beta 2 Microglobulin)IBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Hormones (Hormone)IBA 11/2017
1	SteroidsIBA 11/2017
1	T 0070907IBA 05/2017
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2017
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 01/2017
1	bardoxolone methylIBA 09/2016

Therapy/Procedure

5	Therapeutics 10/2022 - 01/2002
1	Parenteral Nutrition 01/2022
1	Drug Therapy (Chemotherapy) 01/2020